Background and aims: Surgical treatment of peri-implantitis with adjunctive systemic antibiotics may improve short-term clinical, radiographic, and microbiological outcomes, although long-term benefits appear limited. These potential benefits should be carefully weighed against the risk of antimicrobial disturbances. Furthermore, treatment planning should be individualized, taking local risk factors into account. The aim of the thesis is to evaluate the clinical, radiographic, and microbiological outcomes of surgical treatment of peri- implantitis with or without adjunctive antibiotics, identifying potential prognostic factors associated with treatment outcomes, and investigating treatment- induced changes in the salivary microbiome.Materials and methods: Study I was a three-armed randomized placebo- controlled clinical trial of 84 patients referred for peri-implantitis (113 implants). All patient were subjected to resective surgical treatment of peri-implantitis with implant surface decontamination. A seven-day course of systemic antibiotics was given to two groups (A, amoxicillin and metronidazole; B, phenoxymethylpenicillin and metronidazole), whereas one group (C) received placebo tablets. Clinical, radiographic, and microbiological outcomes were evaluated for up to 12 months. Study II was an exploratory post-hoc prognostic analysis of Study I involving 76 patients (104 implants). Mixed models were used to evaluate the association of keratinized tissue width, implant position and location, and baseline inflammation on disease resolution endpoints. Study III was also an exploratory study in which saliva samples were collected from a subset of 27 patient from the two antibiotic groups in Study I at five timepoints over 12 months. Shotgun metagenomic sequencing was used to analyze and compare the changes in microbial composition in saliva over time between the two antibiotic regimens.Results: In Study I 76 patients (104 implants) completed the study. All groups showed clinical and radiological improvements over time. Significant differences were observed between groups for marginal bone level stability, treatment success, and bacterial levels of Aggregatibacter actinomycetemcomitans and Tannerella forsythia, favoring antibiotics compared to placebo. In Study II, baseline site-related factors did not significantly predict overall disease resolution at 12 months after surgery. Nevertheless, a wider band of keratinized tissue was associated with lower probing pocket depths and more favorable marginal bone level changes. Study III revealed a distinct decrease in alpha diversity on day 8 compared to baseline across both antibiotic regimens, with signs of recovery by day 14. No statistically significant differences in alpha or beta diversity were observed between the interventions over 12 months.Conclusion: The thesis provides additional understanding of the clinical, radiographic, and microbiological aspects of peri-implantitis treatment. It demonstrates that adjunctive systemic antibiotics may enhance the outcomes of surgical treatment by improving overall treatment success and marginal bone level stability. Although, baseline site-related factors were not significantly associated with disease resolution, the width of keratinized tissue may be associated with more favorable clinical and radiographic outcomes following treatment. Given the exploratory nature of the post-hoc analysis, these findings should be interpreted with caution. Both antibiotic regimens produced similar alterations in the salivary microbiome, underscoring the importance of balancing the clinical benefits of antibiotic therapy with its ecological consequences and the principles of antibiotic stewardship.List of scientific papersI. Systemic antibiotics in the surgical treatment of peri-implantitis: A randomized placebo-controlled trial. Riben Grundström, C., Lund, B., Kampe, J., Belibasakis, G.N., Hultin, M. Journal of Clinical Periodontology 2024, 51(8), 981-996.https://doi.org/10.1111/jcpe.13994II. Site-related prognostic factors in peri-implantitis surgery: A post hoc analysis of a randomized clinical trial. Riben Grundström, C., Hultin, M., Belibasakis, G.N., Lund, B. [Submitted]III. Riben Grundström C, Lund B, Bostanci N, Silbereisen A, Pennhag A, Koistinen IS, Zha Y, Damdimopoulos A, Belibasakis GN, Hultin M. Systemic Antibiotics in the Surgical Treatment of Peri-Implantitis: Impact on the Salivary Microbiome. J Clin Periodontol. 2026 Aug;53(8):1265-1277.https://doi.org/10.1111/jcpe.70143